Destiny Pharma
      
Skip to content
  • About Us
    • Board of Directors
    • Leadership
    • Scientific Advisory Board
    • Our Values
    • History
  • Pipeline
    • NTCD-M3 for Clostridioides difficile Infections
    • XF-73 Nasal for Post Surgical Infections
    • XF-73 for Dermal Infections
    • SPOR-COV™ for COVID-19
    • XF Research Programs
  • Target Markets
    • Clostridioides difficile Infections
    • Post Surgical Infections
    • Dermal Infections
    • COVID-19
    • Anti-Microbial Resistance
  • Our Technologies
    • Biotherapeutics
      • NTCD-M3
      • SPOR-COV™
    • XF Platform
  • Business Development
  • News and Media
    • Media
    • Events
  • Investors
    • AIM Rule 26
    • Corporate Governance
    • Share Price Information
    • Regulatory News
    • Constitutional Documents
    • Reports & Presentations
    • Advisers / Shareholder Contacts
    • Analyst Coverage
    • Email Alerts
  • Careers
  • Contact

Month: December 2021

16 December 2021 – Destiny Pharma presents at the 3rd Annual Bio Cross-Border Investment & Partnership event

Posted on 16/12/2021 by Kirsty Richardson

Destiny Pharma’s CEO Neil Clark presented virtually at the 3rd Annual Bio Cross-Border Investment & Partnership 2021 in Beijing on 16th December 2021

Posted in News

Biotech Showcase 2022 – 10-12 January 2022

Posted on 16/12/2021 by Kirsty Richardson

Destiny Pharma is presenting at the Biotech Showcase 2022 conference on 10 – 12 January 2022.

If you would like to meet virtually with Destiny Pharma, please email us on conferences@destinypharma.com

Posted in Old Events

3rd Annual Bio Cross-Border Investment & Partnership Summit – 16 December 2021

Posted on 16/12/2021 by Kirsty Richardson

Destiny Pharma is presenting at the 3rd Annual Bio Cross-Border Investment & Partnership Summit on 16 December 2021.

If you would like to meet virtually with Destiny Pharma, please email us on conferences@destinypharma.com

Posted in Old Events

Microbiome Connect: Gut Therapeutics Europe – 7-9 December 2021

Posted on 02/12/2021 by Kirsty Richardson

Destiny Pharma is presenting at the Microbiome Connect: Gut Therapeutics Europe conference on 7 – 9 December 2021.

If you would like to meet virtually with Destiny Pharma, please email us on conferences@destinypharma.com

Posted in Old Events

Share Price

Latest News

  • 24 March 2023 – Landmark XF-73 Phase 2 data published in US journal 24/03/2023
  • 16 March 2023 – Result of General Meeting and Total Voting Rights 17/03/2023
  • 15 March 2023 – Result of Open Offer 17/03/2023

Events

  • Proactive One2One Investor Forum – 23 March 2023 23/03/2023
  • ECCMID – 15-18 April 2023 27/02/2023

Destiny Pharma

© All rights reserved.

Powered by WordPress

Destiny Pharma plc
Sussex Innovation Centre
Science Park Square
Brighton
BN1 9SB
UK

Tel: +44(0) 1273 704440

Registered Company
No. 3167025
About Us
Pipeline
Target Markets
Our Technologies
Business Development
News
Investors
Contact
Terms of Use
Privacy Statement